Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy

• Published in: Archives of physiology and biochemistry 2019-05, Vol.125 (3), p.201-209
• Main Authors: Rehman, Muneeb U., Rashid, Shahzada Mudasir, Rasool, Saiema, Shakeel, Sheeba, Ahmad, Bilal, Ahmad, Sheikh Bilal, Madkhali, Hassan, Ganaie, Majid Ahmad, Majid, Sabiya, Bhat, Showkat Ahmad
• Format: Article
• Language: English
• Subjects: Diabetic nephropathy; inflammation; KIM-1; ROS; zingerone
• ISSN: 1381-3455; 1744-4160
• DOI: 10.1080/13813455.2018.1448422

Development of diabetic nephropathy (DN) is directly linked to oxidative stress and inflammation. In this context, inflammatory and oxidative markers have gained much attention as targets for therapeutic intervention. We studied the effect of zingerone in a streptozotocin/high fat diet (STZ/HFD)-induced type 2 diabetic Wistar rat model. Zingerone also known as vanillyl acetone is a pharmacologically active compound present usually in dry ginger. STZ/HFD caused excessive increase in ROS and inflammation in experimental animals. The treatment with zingerone markedly abrogated ROS levels, inhibited the NF-кB activation and considerably reduced level of other downstream inflammatory molecules (TNF-α, IL-6, IL-1β), furthermore, zingerone treatment improved renal functioning by significantly decreasing the levels of kidney toxicity markers KIM-1, BUN, creatinine, and LDH and suppressed TGF-β. Collectively, these findings indicate that zingerone treatment improved renal function by anti-hyperglycaemic, anti-oxidant, and anti-inflammatory effects, suggesting the efficacy of zingerone in the treatment of DN.